Access cutting-edge cutaneous lupus erythematosus treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access cutaneous lupus erythematosus specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cutaneous lupus erythematosus treatment provided free
The primary purpose of this study is to evaluate the efficacy, safety, and tolerability of IMVT-1402 in participants with Cutaneous Lupus Erythematosus. The study will consist of 3 periods: Period 1: eligible participants will be randomized 1:1 to IMVT-1402 Dose 1 or placebo SC QW for 12 weeks. Period 2: participants who completed Period 1 will receive IMVT-1402 Dose 1 SC QW for 14 weeks. Period 3: after completion of Period 2, participants will be re-randomized 1:1 to blinded IMVT-1402 Dose
Sponsor: Immunovant Sciences GmbH
Check if you qualify for this cutaneous lupus erythematosus clinical trial in Birmingham, AL
If you're searching for cutaneous lupus erythematosus treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cutaneous lupus erythematosus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.